Assessments, outcomes and instruments
After baseline, participants are re-assessed at three different time points over the course of nine months: 6 weeks after baseline (T1), 12 weeks after baseline (T2; post-treatment assessment) and 6 months after post-treatment (T3) (Fig. Table 